AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

The finance minister Nirmala Sitharaman introduced a new scheme "Biopharma Shakti" with an outlay of INR 10,000 Cr for the upcoming five years.

Union Budget 2026 shows that technology, science and innovation are no longer side topics but core to India’s growth plan. While presenting the Budget, Finance Minister Nirmala Sitharaman underlined ...

A Rs 10,000-crore push aims to build India’s biopharma and advanced manufacturing capabilities as disease patterns and technology priorities shift.

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Finance Minister Nirmala Sitharaman set the tone early in her Budget 2026 speech, describing it as the first Budget prepared ...

The robots are coming for health care, just like they are for virtually everything else. But in this very narrow instance, at least, that may actually be a good thing. In the spirit of a week ...

Shane Charter, the underworld figure and biochemist nicknamed “Dr Ageless”, has opened a specialist anti-ageing clinic under a new name.

From massive tax holidays for cloud infrastructure to strategic pushes in semiconductor and AI domains, here is the complete list of key takeaways for the Indian tech and startup ecosystem ...

Synthetic anti-infectives biotech firm Recce Pharmaceuticals has signed a cooperative research and development agreement ...

India's drug regulatory authority, CDSCO, will be strengthened to meet global standards and speed up approvals. A new ...